Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057834 · ClinicalTrials.gov registry record · NA
The Urinary Incontinence Treatment Study
A NA study of Urinary Incontinence and Sarcopenia, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03057834: Completed NA study of Urinary Incontinence and Sarcopenia, sponsored by Wake Forest University Health Sciences.
NCT03057834 is a NA study of Urinary Incontinence and Sarcopenia that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 70 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057834, a NA study of Urinary Incontinence and Sarcopenia, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women in each group. If investigators find unequal numbers, they will adapt recruit strategies based on a woman's functional status.
Primary Outcome
Using a three-day voiding diary
Conditions Studied
Interventions
- BEHAVIORAL Pelvic floor muscle exercise
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2020-01-29 |
| Phase | NA |
What the finished NCT03057834 record still lists
NCT03057834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Pelvic floor muscle exercise is the first listed.
NCT03057834 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03057834 about?
NCT03057834 is a clinical study titled "The Urinary Incontinence Treatment Study". Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women...
What is the current status of trial NCT03057834?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2017-03-01. Estimated completion is 2020-01-29.
What conditions does trial NCT03057834 study?
This clinical trial studies the following conditions: Urinary Incontinence, Sarcopenia.
What interventions are being tested in trial NCT03057834?
The interventions under investigation include: Pelvic floor muscle exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03057834?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03057834 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03057834's enrollment target sits among peer trials
70 29th of 48 higher than 20 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI